Literature DB >> 20359468

Location of chlorhexidine in DMPC model membranes: a neutron diffraction study.

Ivana Komljenović1, Drew Marquardt, Thad A Harroun, Edward Sternin.   

Abstract

Chlorhexidine (CHX) is an effective anti-bacterial agent whose mode of action is thought to be the disruption of the cell membrane. It is known to partition into phospholipid bilayers of aqueous model-membrane preparations. Neutron diffraction data taken at 36 degrees C on the location of CHX in phosphatidylcholine (PC) bilayers is presented. The center of mass of the deuterated hydrocarbon chain of CHX is found to reside 16A from the center of the bilayer in 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine (14:0-14:0PC). This places the drug near the glycerol backbone of the lipid, and suggests a mode of action whereby the molecule is bent in half and inserts wedge-like into the lipid matrix. This mechanism is distinct from detergent-like mechanisms of membrane disruption and more similar to some anti-microbial peptide action, where peptides insert obliquely into the bilayer headgroup region to disrupt its structure. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359468     DOI: 10.1016/j.chemphyslip.2010.03.007

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  13 in total

1.  Chlorhexidine inhibits L1 cell adhesion molecule-mediated neurite outgrowth in vitro.

Authors:  Aaron M Milstone; Penny Bamford; Susan W Aucott; Ningfeng Tang; Kimberly R White; Cynthia F Bearer
Journal:  Pediatr Res       Date:  2013-10-14       Impact factor: 3.756

2.  Effect of Transmembrane Electric Field on GM1 Containing DMPC-Cholesterol Monolayer: A Computational Study.

Authors:  Zarrin Shahzadi; Chaitali Mukhopadhyay
Journal:  J Membr Biol       Date:  2019-11-14       Impact factor: 1.843

3.  Minimizing human infection from Escherichia coli O157:H7 using GUMBOS.

Authors:  Marsha R Cole; Min Li; Ravirajsinh Jadeja; Bilal El-Zahab; Daniel Hayes; Jeffery A Hobden; Marlene E Janes; Isiah M Warner
Journal:  J Antimicrob Chemother       Date:  2013-02-26       Impact factor: 5.790

4.  Chlorhexidine Induces VanA-Type Vancomycin Resistance Genes in Enterococci.

Authors:  Pooja Bhardwaj; Elizabeth Ziegler; Kelli L Palmer
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Phenotypic and genotypic changes of Staphylococcus aureus in the presence of the inappropriate concentration of chlorhexidine gluconate.

Authors:  Neda Baseri; Shahin Najar-Peerayeh; Bita Bakhshi; Floriana Campanile
Journal:  BMC Microbiol       Date:  2022-04-13       Impact factor: 3.605

6.  Promysalin is a salicylate-containing antimicrobial with a cell-membrane-disrupting mechanism of action on Gram-positive bacteria.

Authors:  Rahul D Kaduskar; Giulia Della Scala; Zaaima J H Al Jabri; Stefania Arioli; Loana Musso; Marco R Oggioni; Sabrina Dallavalle; Diego Mora
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

Review 7.  Surfactants - Compounds for inactivation of SARS-CoV-2 and other enveloped viruses.

Authors:  Miriam Simon; Michael Veit; Klaus Osterrieder; Michael Gradzielski
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-06-12       Impact factor: 6.448

8.  Chlorhexidine: beta-cyclodextrin inhibits yeast growth by extraction of ergosterol.

Authors:  K I R Teixeira; P V Araújo; R D Sinisterra; M E Cortés
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

9.  Can probiotics be an alternative to chlorhexidine for oral care in the mechanically ventilated patient? A multicentre, prospective, randomised controlled open trial.

Authors:  Bengt Klarin; Anne Adolfsson; Anders Torstensson; Anders Larsson
Journal:  Crit Care       Date:  2018-10-28       Impact factor: 9.097

10.  Antimicrobial activity of resveratrol-derived monomers and dimers against foodborne pathogens.

Authors:  Luce M Mattio; Sabrina Dallavalle; Loana Musso; Rossella Filardi; Laura Franzetti; Luisa Pellegrino; Paolo D'Incecco; Diego Mora; Andrea Pinto; Stefania Arioli
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.